BWXT AI Stock Analysis – Buy, Hold, or Avoid?
BWX Technologies, Inc. (BWXT)
Fundamentals
BWXT demonstrates solid financial health with consistent revenue growth and improving profitability metrics, underpinned by strong operating income and stable margins. Earnings have shown an upward trajectory reflecting effective cost management and robust demand in the aerospace and defense sector. The company’s fundamentals position it well for sustainable growth despite some valuation stretch and sector-specific risks.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
18.01% YoY
Q2 2026
Net Income
13.66% YoY
Q2 2026
Net Margin
Q2 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q2 2026
Net Income Growth YoY
Latest Quarter: Q2 2026
Revenue Per Share Growth YoY
Latest Quarter: Q2 2026
EPS Growth YoY
Latest Quarter: Q2 2026
Book Value Per Share Growth YoY
Latest Quarter: Q2 2026
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 901.6M | 861.1M | 885.8M | 866.3M | 764.0M | 682.3M | 746.3M | 672.0M |
| Revenue Growth YoY | +18.01% | +26.21% | +18.70% | +28.92% | +12.12% | +12.96% | +2.86% | +13.89% |
| Net Income | 89.1M | 91.2M | 93.0M | 82.1M | 78.4M | 75.5M | 71.0M | 69.5M |
| Net Income Growth YoY | +13.66% | +20.74% | +30.94% | +18.17% | +7.42% | +10.31% | +7.79% | +15.28% |
| EPS | $0.97 | $0.99 | $1.02 | $0.90 | $0.86 | $0.82 | $0.78 | $0.76 |
| EPS Growth YoY | +12.79% | +20.73% | +30.77% | +18.42% | +7.50% | +9.33% | +8.33% | +15.15% |
Profitability Metrics
Technical Analysis
BWXT is currently in a strong downtrend characterized by a death cross and price trading below key moving averages (50, 150, and 200 SMA). Momentum indicators like RSI sit in a neutral zone, while ADX confirms the presence of a strong bearish trend. The stock is in the declining Stage 4 phase, suggesting caution for buyers and potential for further downside pressure.
No extreme reading
Price in downtrend
Strong trend active
50 below 200 - bearish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
BWXT demonstrates solid financial health with consistent revenue growth and improving profitability metrics, underpinned by strong operating income and stable margins. Earnings have shown an upward trajectory reflecting effective cost management and robust demand in the aerospace and defense sector. The company’s fundamentals position it well for sustainable growth despite some valuation stretch and sector-specific risks.
Latest Earnings
Q2 2026 Earnings (Jun 30, 2026)
Earnings Per Share (EPS)
Actual
$1.07
Estimated
$1.04
Surprise
+$0.03
Surprise %
+2.88%
Revenue
Actual
$901.6M
Estimated
$902.8M
Surprise
-$1.2M
Surprise %
-0.13%
Historical Earnings
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $1.07 | $1.12 | $1.08 | $1.00 | $1.02 | $0.91 | $0.92 | $0.83 |
| EPS (Estimated) | $1.04 | $0.92 | $0.89 | $0.85 | $0.79 | $0.77 | $0.80 | $0.78 |
| EPS Surprise | +$0.03 | +$0.20 | +$0.19 | +$0.15 | +$0.23 | +$0.15 | +$0.12 | +$0.05 |
| % Diff | +2.9% | +21.7% | +21.2% | +17.2% | +29.1% | +19.0% | +15.0% | +6.4% |
| Revenue | ||||||||
| Revenue (Actual) | $901.6M | $860.2M | $885.8M | $866.29M | $764.04M | $682.26M | $746.27M | $671.96M |
| Revenue (Estimated) | $902.8M | $837.47M | $837.5M | $793.37M | $794.01M | $645.68M | $653.16M | $658.84M |
| Revenue Surprise | -$1.2M | +$22.73M | +$48.3M | +$72.92M | -$29.98M | +$36.57M | +$93.11M | +$13.12M |
| % Diff | -0.1% | +2.7% | +5.8% | +9.2% | -3.8% | +5.7% | +14.3% | +2.0% |
Valuation
BWXT is currently trading at a premium valuation with elevated multiples compared to the broader Aerospace & Defense industry. While its financial performance shows strong revenue and earnings growth supported by defense and clean energy demand, the valuation reflects ambitious future expectations. Consensus analyst ratings lean moderately bullish with a price target suggesting upside potential, though at a valuation that includes a growth premium.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 50.17 | 51.64 | 42.36 | 51.21 | 41.88 | 30.08 | 35.70 | 35.76 |
| Price to Sales | 19.80 | 21.77 | 17.87 | 19.49 | 17.26 | 13.24 | 13.67 | 14.81 |
| Price to Book | 13.38 | 14.64 | 12.84 | 13.60 | 11.14 | 8.21 | 9.44 | 9.40 |
| Enterprise Value to EBITDA | 174.12 | 143.53 | 122.99 | 122.02 | 107.36 | 82.27 | 101.85 | 91.55 |
| Enterprise Value to Revenue | 22.04 | 23.51 | 19.57 | 21.13 | 19.22 | 14.92 | 14.99 | 16.59 |
Sentiment & Analyst Ratings
BWXT is currently viewed positively by analysts and investors, buoyed by strong contract wins, recent acquisitions expanding its nuclear manufacturing capacity, and upcoming earnings expectations that beat forecasts. While its valuation may appear elevated to some specialists, the broad sentiment remains optimistic, supported by solid revenue growth and upgraded analyst price targets signaling significant upside potential.
Analyst Recommendations
Risk Assessment
BWXT demonstrates strong liquidity and manageable leverage with improving short-term financial health, supported by solid current and quick ratios well above industry thresholds. However, the company faces moderate financial risk due to elevated debt levels relative to equity and exposure to federal budget uncertainties and regulatory risks in the nuclear sector. Overall, BWXT's risk profile is moderate, balancing stable operational cash flow against sector-specific and macro risks.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q2 2026
Quick Ratio
Latest Quarter: Q2 2026
Debt-to-Equity
Latest Quarter: Q2 2026
Debt-to-Assets
Latest Quarter: Q2 2026
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 0.00 | 2.40 | 2.32 | 1.71 | 1.69 | 2.02 | 1.96 | 2.25 |
| Quick Ratio | 0.00 | 2.33 | 2.25 | 1.62 | 1.60 | 1.91 | 1.88 | 2.16 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 1.51 | 1.58 | 1.64 | 1.22 | 1.29 | 1.09 | 0.98 | 1.16 |
| Debt-to-Assets | 0.00 | 0.47 | 0.47 | 0.40 | 0.41 | 0.39 | 0.37 | 0.42 |
Liquidity Assessment
Current Ratio: 0.000
Quick Ratio: 0.000
The company has relatively weak liquidity and may face challenges meeting short-term obligations.
Solvency Assessment
Debt-to-Equity: 1.51(High)
Debt-to-Assets: 0.000
The company has relatively high debt levels, which may increase financial risk in economic downturns.
Frequently Asked Questions about BWXT
AI Answers: Common Questions About BWXT
Get AI-powered answers to the questions investors ask most about BWX Technologies, Inc.
BWXT is a good long-term buy due to strong fundamentals and growth prospects, but near-term technical weakness advises caution. The P/E ratio of nearly 40 and premium valuation require confidence in sustained earnings growth.
Short-term traders may consider selling or avoiding new positions due to bearish technical signals and price below key moving averages. Long-term investors should hold unless fundamentals deteriorate.
Key risks include potential federal budget cuts, regulatory changes in nuclear operations, supply chain issues, inflation impacting costs, and geopolitical uncertainties affecting defense spending.
Analyst consensus price targets imply approximately 35% upside from the current $168.70 price, with resistance near $188 and $197 on technical charts and support near $143.
BWXT is currently overvalued relative to its sector with a P/E of 39.98, high EV/EBITDA, and price-to-sales ratios reflecting strong growth expectations but limited margin for error.
The company shows consistent revenue growth around 15% YoY, improving operating margins near 14%, and strong EPS growth over 30% YoY, supported by stable government contracts and operational efficiencies.
Technically bearish with a death cross, price below all major SMAs, and strong ADX trend confirmation. RSI is neutral but momentum favors downside with support near $143.
Upcoming catalysts include new government contract awards, integration of recent acquisitions, and quarterly earnings releases that may beat estimates and drive sentiment.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.